MacLean, Catherine H. MD, PhD*†§; Louie, Rachel MS†; Shekelle, Paul G. MD, PhD*†; Roth, Carol P. RN, MPH*; Saliba, Debra MD, MPH*†; Higashi, Takahiro MD¶†; Adams, John PhD*; Chang, John T. MD, MPH*¶; Kamberg, Caren J. MSPH‡; Solomon, David H. MD†; Young, Roy T. MD†¶; Wenger, Neil S. MD, MPH†¶
From the *Greater Los Angeles VA Healthcare System, California; †RAND Health, Santa Monica, California; ‡RAND Health, Arlington, Virginia; and §Division of Rheumatology and ¶Division of General Internal Medicine, the David Geffen School of Medicine at UCLA.
Drs. MacLean and Saliba are VA HSR&D Career Development Awardees. Dr. Shekelle is a Senior Research Associate of the Veterans Affairs Health Services Research and Development Service. Dr. Chang is supported by a National Research Service Award (PE-19001) and the University of California, Los Angeles, Specialty Training and Advanced Research (STAR) Program. This project was supported by a contract from Pfizer Inc to RAND.
Pfizer had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation or approval of this manuscript. Pfizer did review this manuscript in advance of submission but did not provide comment to the authors.
Reprints: Catherine H. MacLean, MD, PhD, RAND, 1776 Main Street, M-26, Santa Monica, CA 90407-2138. E-mail: [email protected].